N1-guanyl-1, 7-diaminoheptane enhances the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine via the inhibition of eukaryotic translation initiation factor 5A2

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy due to its broad resistance to chemotherapy. Gemcitabine is used as a standard chemotherapeutic drug for PDAC treatment, either alone or in combination with other chemotherapeutics. However, in patients with advanced disease,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Minya, Hong, Yun, Liu, Yu, Chen, Wei, Wang, Weilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609100/
https://www.ncbi.nlm.nih.gov/pubmed/28962130
http://dx.doi.org/10.3892/etm.2017.4740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609100/
https://www.ncbi.nlm.nih.gov/pubmed/28962130
http://dx.doi.org/10.3892/etm.2017.4740

Ejemplares similares